Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
7.60
+0.27 (3.68%)
At close: Aug 13, 2025, 4:00 PM
7.60
0.00 (0.00%)
Pre-market: Aug 14, 2025, 8:15 AM EDT

Trevi Therapeutics Market Cap

Trevi Therapeutics has a market cap or net worth of $925.50 million as of August 14, 2025. Its market cap has increased by 317.14% in one year.

Market Cap
925.50M
Enterprise Value
722.51M
1-Year Change
317.14%
Ranking
Category
Stock Price
$7.60

Market Cap Chart

Since May 7, 2019, Trevi Therapeutics's market cap has increased from $84.99M to $925.50M, an increase of 988.97%. That is a compound annual growth rate of 46.31%.

History

DateMarket Cap% Change
Aug 13, 2025925.50M151.37%
Dec 31, 2024368.19M330.28%
Dec 29, 202385.57M-26.01%
Dec 30, 2022115.65M472.04%
Dec 31, 202120.22M-54.55%
Dec 31, 202044.48M-33.49%
Dec 31, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 570.02B
Johnson & Johnson 419.03B
AbbVie 349.81B
Abbott Laboratories 229.39B
UnitedHealth Group 228.99B
Novartis AG 228.69B
AstraZeneca 227.85B
Novo Nordisk 222.88B
Market Cap Rankings